A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Clinical trial NCT03966898 · UNKNOWN
Trial details
- NCT number
- NCT03966898
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-19
- Primary completion
- 2022-12-30
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.